NCT06619665 - A Study of MK-6552 in Sleep Deprived Healthy Participants (MK-6552-003) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 19, 2024

Primary Completion Date

July 16, 2024

Study Completion Date

July 16, 2024

Conditions

HealthyNarcolepsy

Interventions

DRUG

MK-6552

MK-6552 gelatin coated capsules taken orally two times 8 hours apart

DRUG

MK-6552 placebo

MK-6552 placebo gelatin coated capsules taken orally two times 8 hours apart

DRUG

Modafinil

Modafinil tablet taken once orally

DRUG

Modafinil placebo

Modafinil placebo tablet taken once orally

Trial Locations (2)

NeuroTrials Research Inc (Site 0001), Atlanta

Clinilabs (Site 0003), Eatontown

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY